Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study

Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study. Diabetes Care. 2026 Sep 21:dca260039. doi: 10.2337/dca26-0039. Epub ahead of print. PMID: 42765974.


Related Posts